These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1922377)

  • 1. Cracks in the RAC.
    Gershon D
    Nature; 1991 Oct; 353(6345):591. PubMed ID: 1922377
    [No Abstract]   [Full Text] [Related]  

  • 2. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene advisory group switches focus to ethical issues.
    Gavaghan H
    Nature; 1994 Oct; 371(6497):468. PubMed ID: 7935752
    [No Abstract]   [Full Text] [Related]  

  • 4. Federal agency keeps review committee after public comments support continuation.
    Maloney DM
    Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
    [No Abstract]   [Full Text] [Related]  

  • 5. RAC defers to NIH director on some gene therapy cases.
    Gershon D
    Nature; 1993 Jan; 361(6409):196. PubMed ID: 8423842
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene therapy panel gets a thumbs up.
    Science; 1995 Nov; 270(5240):1287. PubMed ID: 11644754
    [No Abstract]   [Full Text] [Related]  

  • 7. Review panel cancels meeting as gene therapy proposals fall.
    Wadman M
    Nature; 1996 Feb; 379(6567):668. PubMed ID: 11644770
    [No Abstract]   [Full Text] [Related]  

  • 8. NIH review to suggest streamlined handling of gene therapy bids.
    Taylor R
    Nature; 1995 Jun; 375(6534):713. PubMed ID: 7596397
    [No Abstract]   [Full Text] [Related]  

  • 9. Department of Health and Human Services, Public Health Service, National Institutes of Health. Recombinant DNA Advisory Committee, Human Gene Therapy Subcommittee. Minutes of meeting, December 9, 1988.
    Recomb DNA Tech Bull; 1989 Mar; 12(1):29-45. PubMed ID: 2657876
    [No Abstract]   [Full Text] [Related]  

  • 10. Keeping faith in gene manipulation.
    Nature; 1996 Jul; 382(6588):191. PubMed ID: 8717027
    [No Abstract]   [Full Text] [Related]  

  • 11. A word to Varmus.
    Pryor D; Hatfield M; Wyden R; Waxman HA
    Hastings Cent Rep; 1996; 26(4):46-7. PubMed ID: 11644858
    [No Abstract]   [Full Text] [Related]  

  • 12. Government regulation of human gene therapy.
    Gage JL
    Jurimetrics; 1987; 27(2):200-18. PubMed ID: 11651978
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy approval may be rocky road for industry.
    Gavaghan H
    Nature; 1995 Mar; 374(6519):202. PubMed ID: 7885431
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a points to consider document for human somatic cell gene therapy.
    Milewski EA
    Recomb DNA Tech Bull; 1985 Dec; 8(4):176-80. PubMed ID: 3867980
    [No Abstract]   [Full Text] [Related]  

  • 15. Exempt research: procedures in the intramural research program of the National Institutes of Health.
    Wichman A; Mills D; Sandler AL
    IRB; 1996; 18(2):3-5. PubMed ID: 11654755
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond localism: a proposal for a National Research Review Board.
    Levine C; Caplan AL
    IRB; 1986; 8(2):7-9. PubMed ID: 11649751
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
    Gordon VM; Sugarman J; Kass N
    IRB; 1998; 20(1):1-5. PubMed ID: 11655324
    [No Abstract]   [Full Text] [Related]  

  • 18. Orkin-Motulsky panel calls for gene therapy basic research.
    Fox JL
    Gene Ther; 1996 Jan; 3(1):pre-1. PubMed ID: 11644882
    [No Abstract]   [Full Text] [Related]  

  • 19. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM
    Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety boards must report their conclusions to IRBs.
    Maloney DM
    Hum Res Rep; 1999 Oct; 14(10):3. PubMed ID: 11658061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.